(Q44276973)

English

Antimicrobial susceptibility profile of molecular typed cystic fibrosis Stenotrophomonas maltophilia isolates and differences with noncystic fibrosis isolates

scientific article published in February 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Antimicrobial susceptibility profile of molecular typed cystic fibrosis Stenotrophomonas maltophilia isolates and differences with noncystic fibrosis isolates (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

cystic fibrosis

0 references

Stenotrophomonas maltophilia

1 reference

based on heuristic

inferred from title

Sylvia Valdezate

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

author name string

Rafael Cantón

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Ana Vindel

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Begoña Sánchez Del Saz

4

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Luis Maíz

5

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Fernando Baquero

6

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

publication date

1 February 2003

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Pediatric Pulmonology

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

35

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

99-107

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Microbiology of sputum from patients at cystic fibrosis centers in the United States

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10216

21 January 2018

Susceptibility of Xanthomonas maltophilia to six quinolones and study of outer membrane proteins in resistant mutants selected in vitro

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10216

21 January 2018

Antimicrobial treatment of pulmonary colonization and infection by pseudomonas aeruginosa in cystic fibrosis patients

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10216

21 January 2018

Emergence of ofloxacin-resistant Citrobacter freundii and Pseudomonas maltophilia after ofloxacin therapy.

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10216

21 January 2018

Multiple antibiotic resistance in Stenotrophomonas maltophilia: involvement of a multidrug efflux system

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10216

21 January 2018

Plasmid location and molecular heterogeneity of the L1 and L2 beta-lactamase genes of Stenotrophomonas maltophilia.

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10216

21 January 2018

Persistence and variability of Stenotrophomonas maltophilia in cystic fibrosis patients, Madrid, 1991-1998.

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10216

21 January 2018

Selective media for the quantitation of bacteria in cystic fibrosis sputum.

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10216

21 January 2018

Genomic diversity of the genus Stenotrophomonas

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10216

21 January 2018

Comparative activities of ciprofloxacin, clinafloxacin, gatifloxacin, gemifloxacin, levofloxacin, moxifloxacin, and trovafloxacin against epidemiologically defined Acinetobacter baumannii strains

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10216

21 January 2018

Survival of Stenotrophomonas maltophilia following exposure to concentrations of tobramycin used in aerosolized therapy for cystic fibrosis patients

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10216

21 January 2018

Susceptibilities of 123 Xanthomonas maltophilia strains to clinafloxacin, PD 131628, PD 138312, PD 140248, ciprofloxacin, and ofloxacin

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10216

21 January 2018

Comparative in vitro activity of gatifloxacin against Stenotrophomonas maltophilia and Burkholderia species isolates including evaluation of disk diffusion and E test methods.

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10216

21 January 2018

Sequential ciprofloxacin therapy in pediatric cystic fibrosis: comparative study vs. ceftazidime/tobramycin in the treatment of acute pulmonary exacerbations. The Cystic Fibrosis Study Group

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10216

21 January 2018

Clinical implications of stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole: a study of 69 patients at 2 university hospitals

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10216

21 January 2018

Stenotrophomonas maltophilia in cystic fibrosis: incidence and prevalence

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10216

21 January 2018

Susceptibility of 100 strains of Stenotrophomonas maltophilia to three beta-lactams and five beta-lactam-beta-lactamase inhibitor combinations

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10216

21 January 2018

Risk factors for emergence of Stenotrophomonas maltophilia in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10216

21 January 2018

Typing of 154 clinical isolates of Stenotrophomonas maltophilia by pulsed-field gel electrophoresis and determination of the in vitro susceptibilities of these strains to 28 antibiotics

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10216

21 January 2018

Comparative in vitro activity of quinolones against Stenotrophomonas maltophilia

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10216

21 January 2018

Comparative activity of new quinolones against 326 clinical isolates of Stenotrophomonas maltophilia

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10216

21 January 2018

In vitro activity of minocycline against respiratory pathogens from patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10216

21 January 2018

Identifiers

10.1002/PPUL.10216

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44276973&oldid=2109082523"